“[Complementary Strategy of RSVpreF Vaccination Nirsevimab Versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 26, no. 1, July 2025, https://doi.org/10.7175/fe.v26i1.1583.